Androgens Modulate the Immune Profile in a Mouse Model of Polycystic Ovary Syndrome.

Autor: Torstensson S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden., Ascani A; Department of Internal Medicine, Medical University of Graz, Auenbruggerplaz 15, Graz, 8036, Austria., Risal S; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden., Lu H; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden., Zhao A; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden., Espinosa A; Department of Medicine, Karolinska Institutet, K2 Reuma Wahren-Herlenius M, Stockholm, 171 77, Sweden., Lindgren E; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden., Johansson MH; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 171 77, Sweden., Eriksson G; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden., Barakat M; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden., Karlsson MCI; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 171 77, Sweden., Svensson C; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden., Benrick A; Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Box 432, Gothenburg, 40530, Sweden., Stener-Victorin E; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden.

Publikováno v: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Jul; Vol. 11 (28), pp. e2401772. Date of Electronic Publication: 2024 May 20.

Retuning of Mouse NK Cells after Interference with MHC Class I Sensing Adjusts Self-Tolerance but Preserves Anticancer Response

Autor: Wagner AK, Wickström SL, Tallerico R, Salam S, Lakshmikanth T, Brauner H, Höglund P, Carbone E, Johansson MH, Kärre K.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3977::8477b671ec3ec6f3fba3451fc7b4060e
http://hdl.handle.net/11591/422201

Comparative Genomics of Three Hybrid-Pathogen Multidrug-Resistant Escherichia coli Strains Isolated from Healthy Donors' Feces.

Autor: Ortega-Enríquez, Judith Z.^1,2 (AUTHOR) judithzullim1802@gmail.com, Martínez-de la Peña, Claudia¹ (AUTHOR) claudia.martinez@correo.buap.mx, Lara-Ochoa, Cristina³ (AUTHOR) cristina.laraochoa@correo.buap.mx, Rocha-Gracia, Rosa del Carmen¹ (AUTHOR) rosa.rocha@correo.buap.mx, Barrios-Villa, Edwin^1,2 (AUTHOR) edwin.barrios@unison.mx, Arenas-Hernández, Margarita M. P.¹ (AUTHOR) edwin.barrios@unison.mx

Publikováno v: Microbiology Research. Sep2024, Vol. 15 Issue 3, p1412-1424. 13p.

NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy.

Autor: Sottile R; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Tannazi M; Department of Pharmaceutical Science, Faculty of Science, Utrecht University, Utrecht, Netherlands., Johansson MH; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Cristiani CM; Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy., Calabró L; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Ventura V; Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy., Cutaia O; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Chiarucci C; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Covre A; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Garofalo C; Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy., Pontén V; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala University Hospital, Uppsala, Sweden., Tallerico R; Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy., Frumento P; Institute of Environmental Medicine, Unit of Biostatistics, Karolinska Institutet, Stockholm, Sweden., Micke P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala University Hospital, Uppsala, Sweden., Maio M; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy., Kärre K; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Carbone E; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.; Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy.

Publikováno v: International journal of cancer [Int J Cancer] 2019 Oct 15; Vol. 145 (8), pp. 2238-2248. Date of Electronic Publication: 2019 May 13.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.